Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FYCOMPA
- Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
- A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
- Fycompa in Catamenial Epilepsy
- Post-stroke Epilepsy: Primary Prophylaxis Study
- Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
- Effect of Perampanel on Peritumoral Hyperexcitability in HGG
- Perampanel Titration and Cognitive Effects
- A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
- Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis
- Fycompa Titration Intervals and Effects on Retention Rate
- Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients
- Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
- Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)
- A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)
- Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy
- Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
- Fycompa in Subjects With Small Fiber Neuropathy (SFN)
- An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects
- Perampanel in Seizure Patients With Primary Glial Brain Tumors
- To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
- A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years
- A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)
Clinical trials list
click for details